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Transplacental transmission (TPT) of wild-type Indian BTV-1 had never been experimentally proved. 
This study was first time investigated TPT of Indian BTV-1 (isolated from aborted and stillborn goat fetal 
spleens). The sequential pathology, virological and immune cell kinetics (CD4+, CD8+ T-lymphocytes 
and NK cells in spleen and PBMCs), and apoptosis in IFNAR1-blocked pregnant mice during early 
(infected on 1 GD) and mid (infected on 8 GD) gestation have been studied. There was higher rate 
of TPT during mid stage (71.43%) than early (57.14%) stage. In early stage reduced implantation 
sites, early embryonic deaths, abortions, and necro-haemorrhagic lesions had observed. Mid stage, 
congenital defects and neurological lesions in foetuses like haemorrhages, diffuse cerebral edema, 
necrotizing encephalitis and decreased bone size (Alizarin red staining) were noticed. BTV-1 antigen 
was first time demonstrable in cells of mesometrium, decidua of embryos, placenta, uterus, ovary, 
and brain of foetuses by immunohistochemistry and quantified by real-time qRT-PCR. BTV-inoculated 
mice were seroconverted by 7 and 5 dpi, and reached peak levels by 15 and 9 dpi in early and mid 
gestation, respectively. CD4+ and CD8+ cells were significantly decreased (increased ratio) on 7 dpi but 
subsequently increased on 15 dpi in early gestation. In mid gestation, increased CD8+ cells (decreased 
ratio) were observed. Apoptotic cells in PBMCs and tissues increased during peak viral load. This first 
time TPT of wild-type Indian BTV-1 deserves to be reported for implementation of control strategies. 
This model will be very suitable for further research into mechanisms of TPT, overwintering, and 
vaccination strategies.
Bluetongue (BT) is a non-contagious, insect-borne (mainly biting midges of Culicoides spp.) disease of domes-
tic (primarily sheep) and wild ruminants, caused by bluetongue virus (BTV). BTV is the prototype member of 
the genus Orbivirus in the family Reoviridae1. Most prominent clinical signs of BT are usually seen in sheep. 
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Subclinical or mild signs are seen in cattle and goats, until the emergence of BTV-1 and BTV-8 in Northern 
Europe2,3. BT is a notifiable disease, listed by World Organization for Animal Health (OIE) and causes huge 
socio-economic losses and hindrance to the international trade of animals and animal products. BT in sheep 
causes severe haemorrhagic syndrome characterized by fever, oedema, haemorrhages, dyspnoea, mucosal ero-
sions and ulcerations, and coronitis3. BTV infection in pregnant animals has led to abortions, congenital deform-
ities and cerebral malformations such as hydranencephaly, and also the birth of viraemic calves4–7.
Till date, 27 distinct BTV serotypes have been described. Between the serotypes, large genetic and pheno-
typic variations were observed related to geographical origins called as BTV topotypes. The reassortment of BTV 
genome segments due to both genetic drift and genetic shift resulted in emergence of BTV strains with enhanced 
virulence8 or adaptation into new ecological zones1.
Before 2006, transplacental transmission (TPT) of field or wild BTV strains was not reported, unlike modified 
live or attenuated vaccine viruses of 4 strains namely, BTV-10, -11, -13 and -17 in cattle1,6. In August 2006, first 
TPT of wild BTV-8 was reported in Western Europe9. The infection thereafter spread to most parts of the north-
ern Europe and caused disease in sheep and cattle10,11. TPT rate varies according to the species, around 10%10 to 
41.7%12,13 in cows, 56 to 69% in ewes14,15 and 33% in goats16, and stage of gestation7. Most important consequences 
of TPT are birth of BTV positive foetuses and viral persistence in heifers resulted in introduction of BTV in dis-
ease free regions11.
The drawbacks of experimental studies in natural host species like ruminants includes expensive, ethical 
issues, inclusion of less number of animals, and difficult in getting BTV sero-negative animals17,18. To overcome 
these constrains, an alternative adult mice model is required. However, adult mice were neither susceptible to 
BTV infection nor viremia was observed after intravenous (I/V) or subcutaneous (S/C) inoculation due to abnor-
mally excessive levels of type I interferon (IFN) production after BTV infection17–19. Calvo-Pinilla et al.17 char-
acterized an IFN alpha/beta receptors deficient [IFNAR(−/−)] adult mice model for in vivo study of various BTV 
serotypes.
BTV serotype-1 was isolated first time from aborted and stillborn goat foetuses from Sardarkrushinagar, 
Gujarat state, India in 200720. Before 2007, no cases of transplacental infection of BTV serotypes in ruminants 
have been reported from India. BTV-1 was isolated from foetuses, which indicated the first evidence of TPT of 
wild-type BTV-1 from India and attenuated or laboratory adapted BTV-1 strains have never been used in this 
region. This Indian BTV-1 showed unusual clinical manifestation, more than 50% of pregnant goats were aborted 
or gave birth to dead kids. But to prove this natural case of TPT of Indian BTV-1, experimental studies are com-
pletely lacking.
Even though BTV infection has occurred in India since 196421, not much is known about the possible birth 
defects associated with TPT of Indian BTV in animals, and distribution of viral antigen in reproductive organs 
has not been described. The clinical, gross, and histopathological findings in pregnant animals infected with 
wild-type BTV-1 have only been rarely addressed in the literature. To best of our knowledge, there is no published 
report available regarding localization of BTV-1 antigen in urerus, placenta, ovary and foetuses by immunohis-
tochemistry, humoral and cell mediated immune response, and apoptosis in pregnant animals infected with wild 
type BTV-1. Researchers are looking to explore the mechanism of transplacental transmission of BTV for better 
understanding of epidemiology and overwintering mechanism of the virus.
Therefore, the objectives of the present study were to explore the TPT potential of wild Indian BTV-1 at early 
and mid stages of gestation after experimental infection in IFNAR1-blocked mice. The present study, first time 
describes the pathological consequences associated with TPT of BTV-1 infection. This study also demonstrated 
the distribution of BTV-1 antigen in reproductive organs, immune cell kinetics and apoptosis in BTV-1 infected 
pregnant animals during early and mid stages of gestation.
Materials and Methods
Animals. The female virgin Swiss albino mice of 6–8 weeks old were procured from Laboratory Animal 
Resource (LAR) Section, ICAR-Indian Veterinary Research Institute (ICAR-IVRI), Izatnagar. The animals were 
kept in polypropylene cages at room temperature (RT; 24 ± 10 °C) and relative humidity of 60 ± 10% with 12/12 h 
light/dark cycle, and provided feed and water ad libitum. The mice were maintained in insect proof accom-
modation of Experimental Animal Facility of Centre for Animal Disease Research and Diagnosis (CADRAD), 
ICAR-IVRI, Izatnagar. All the experiments were performed in accordance to the regulations and guidelines 
approved by the Institute Animal Ethics Committee (IAEC), ICAR-IVRI, Izatnagar [Approval No. F26-1/2015-
16/JD(R)]. All animal procedures were conducted in accordance with the Committee for the Purpose of Control 
and Supervision on Experiments on Animals (CPCSEA) guidelines (2003).
The stage of estrous cycle was identified by visual examination of vagina, based on the criteria described by 
Champlin et al.22. The mice in proestrus and estrus stages were kept for breeding. Two females and one adult fer-
tile male mice of the same strain were kept for mating (2:1 ratio). During the mating period, vagina was examined 
every morning for the presence of copulatory plug and the presence of sperm was confirmed microscopically 
using vaginal swabs. The day of finding of copulatory plug was considered as 1 gestation day (GD).
Experimental Design
Experiment-1. After confirmation of copulatory plug, mice were inoculated intravenously (I/V) with 50 μl 
of inoculum containing 1 × 106 TCID50/ml of BTV-1 at 1 GD and acted as infected group. The mice were injected 
with mouse anti-mouse interferon α/β receptor (IFNAR1 subunit) monoclonal antibody (Prod. No. I-401; Clone: 
MAR1-5A3; Leinco Technologies, Inc., St. Louis, Missouri, USA) at a dose rate of 2.5 mg/mouse intraperitoneally 
(I/P) at 24 hours before BTV-1 infection23,24. The control mice were inoculated with 50 μl of uninfected tissue 
culture medium, I/V and anti-mouse IFNAR1 monoclonal antibody (2.5 mg/mouse, I/P) before 24 h of PBS and 
acted as placebo. The control mice were housed in a separate pen without contact with BTV infected animals. 
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Three mice from BTV-1 inoculated and two mice from control pregnant groups were sequentially euthanized by 
cervical dislocation on 1 (2 GD), 2 (3 GD), 3 (4 GD), 5 (6 GD), 7 (8 GD), 9 (10 GD), 12 (13 GD), 15 (16 GD), 18 
(19 GD), and 19/20 (20/21 GD) days post infection (dpi). The dams and all foetuses were examined thoroughly 
during post-mortem and body weight of foetuses was recorded.
Experiment-2. The mid stage pregnant mice were inoculated I/V with 50 μl of inoculum containing 1 × 106 
TCID50/ml of BTV-1 at 8 GD and acted as infected group. The mice were injected with anti-mouse IFNAR1 mon-
oclonal antibody at a dose rate of 2.5 mg/mouse, I/P at 24 hours before BTV-1 infection. The control mid pregnant 
mice received I/V 50 μl of uninfected tissue culture medium and 24 h before, anti-mouse IFNAR1 monoclonal 
antibody at a dose rate of 2.5 mg/mouse, I/P and acted as placebo. Three mice from BTV-1 inoculated and two 
mice from control pregnant groups were sequentially euthanized by cervical dislocation on 1 (9 GD), 2 (10 GD), 
3 (11 GD), 5 (13 GD), 7 (15 GD), 9 (17 GD), and 12/13 (20/21) dpi. The dams and all foetuses were examined 
thoroughly during post-mortem and body weight of foetuses was recorded.
inocula. The bluetongue virus serotype-1 used in this experiment was isolated from stillborn and aborted fetal 
spleens of goats in July 2007 at Sardarkrushinagar, Gujarat, India20. The BTV-1 had caused 52% of abortions and 
birth of dead stillborn kids in 3 months of pregnant goats (13/25). The BTV-1 (SKN-10/India/2007) was supplied 
by Virus Repository of ICAR-All India Network Program on Bluetongue (AINP-BT), ICAR-IVRI, Mukteswar 
Campus, Uttarakhand, India. BTV-1 was isolated on baby hamster kidney cells (BHK-21) and passaged once on 
Culicoides sonorensis (KC) cell line, to obtain virus stock for inoculation. The virus stock was titrated in BHK-
21 cells to determine a titre of TCID50/ml by endpoint titration assay and diluted in cell culture medium before 
inoculation. Serotype specific PCR was performed using BTV-1 segment 2 (VP2) primers to confirm the BTV 
serotype (Table 1).
Clinical observations. The pregnant mice were observed daily and recorded for mortality and clinical signs 
like dullness, anorexia, ocular and nasal discharges, respiratory signs, abortion, stillbirth, staining around the 
perineum, behaviour and nervous signs.
Post-mortem lesions. Systematic post-mortem examination was carried out and gross findings were 
recorded. The uterus of each dam was examined to record the number of implantation sites, total number of 
embryos and/or foetuses, number of live and dead embryos and/or foetuses, and number of mummified and/
or macerated foetuses. Further, macroscopic abnormalities in the foetuses were checked carefully. The axillary 
and inguinal lymph nodes, lungs, spleen, heart, thymus, brain, liver, etc. examined for gross lesions. The effect of 
BTV-1 on early and mid stages of gestation was compared with control uninfected pregnant mice.
Sample collection. To avoid cross-contamination, control mice were autopsied first and separate sterilized 
equipments were used for each infected animal for sampling. At euthanasia, blood was collected from hearts of 
both infected and control mice in EDTA coated vacutainers for haematological studies, fluorescent activated cell 
sorting (FACS) analysis, and BTV RNA quantification. Blood was also collected in BD Vacutainer® plus plastic 
SST™ with Polymer Gel tubes for serum separation for BTV-1 antibody detection. Tissues from axillary and 
inguinal lymph nodes, lungs, spleen, heart, thymus, brain, liver, kidneys, uterus, placenta, ovaries, embryos, entire 
foetuses, and foetal organs were collected in 10% neutral buffered formalin (NBF) for histopathology and immu-
nohistochemisry (IHC), and in RNAlater® (Ambion, USA) for BTV-1 detection, and stored at −80 °C. Care was 
taken to avoid contamination of foetuses with maternal blood. The spleens were collected in RPMI-1640 medium 
(Sigma-Aldrich, St. Louis, Missouri, USA) in ice for FACS analysis.
The embryos were too small and difficult to dissect them for individual organ sampling. Therefore, few 
embryos were fixed as such without dissection in 10% NBF for histopathology and IHC, and few embryos were 
frozen at −80 °C for virus detection. The contents of each entire embryo was homogenized and treated as one 
sample. On 20/21 GD only, individual organs of foetuses were sampled.
Histopathology. The formalin-fixed tissues were cut into pieces of 2 to 3 mm thickness and washed with 
water, dehydrated in ascending grades of alcohol, and cleared in xylene. The dehydrated tissues were embedded in 
















20TaqMan probe# 5′-(6-FAM)-ARG CTG CAT 
TCG CAT CGT ACG C-(Tamra-Q)-3′
Table 1. Primers used in this study for amplification of BTV genome. *R = A + G, Y = C + T. #The oligo 
sequence has been labeled with reporter FAM (Carboxyfluorescein) at 5′ end and quencher Tamra at 3′ end. The 
sequence is a part of segment 10 (NS3), the conserved region present in all BTV serotypes.
4Scientific RepoRtS |         (2020) 10:2164  | https://doi.org/10.1038/s41598-020-58268-0
www.nature.com/scientificreportswww.nature.com/scientificreports/
RNA extraction. Total RNA was extracted from EDTA stabilized blood and various tissues preserved in 
RNAlater® (Ambion, USA) using TRIzol™ reagent (Invitrogen™, ThermoFisher Scientific, Carlsbad, CA, USA) 
as per manufacturer’s recommendations. The total RNA suspension was treated with RQ1 (RNA Qualified) 
RNase-Free DNase enzyme (Promega, WI, USA) followed by enzyme inactivation at 65 °C for 10 min to remove 
the possible traces of genomic DNA. Purity of the RNA was analysed in spectrophotometry and integrity of the 
RNA was tested by electrophoresis. The final RNA pellet was stored at −80 °C.
Quantification of BTV genome by real-time qRT-PCR. The viral loads in blood and various tissue 
samples at specified time points were quantified by Taqman probe based real-time polymerase chain reac-
tion (PCR) using NS3 probe and primers specific for BTV segment 10 (Table 1) as described previously25. The 
QIAGEN® OneStep RT-PCR Kit (Qiagen, Hilden, Germany) was used in CFX96™ Real-Time System (BIO-RAD, 
USA). A volume of 25 μl of PCR reaction mix was prepared with 2 μg of RNA as template combined with 10 pmol 
each of forward and reverse primers and probe with other components in the reactions according to the manufac-
turer’s instructions. The cycling conditions were reverse transcription at 50 °C for 30 min, initial PCR activation at 
95 °C for 15 min, template denaturation at 94 °C, primer annealing at 56 °C, extension at 72 °C for 30 sec, and final 
extension at 72 °C for 10 min. Individual cycle threshold (Ct) values were determined from the point at which the 
level of fluorescence passed a threshold fluorescence line. The real-time qRT-PCR amplification was confirmed 
by dissociation curve at the end of reaction. The real-time PCR products were further confirmed by 1.5% agarose 
gel electrophoresis and visualized under UV light after staining with ethidium bromide. The standard curve was 
used for the quantification of BTV RNA in samples.
Immunohistochemistry. Duplicate formalin fixed tissue sections were taken on (3-Aminopropyl)trieth-
oxysilane (APES, Sigma Aldrich, St. Louis, Missouri, USA) coated glass slides. BTV-1 antigen localisation was 
demonstrated in lymph nodes, lungs, spleen, brain, placenta, uterus, ovary, and foetal tissues of pregnant mice 
by indirect immunoperoxidase technique (IPT) using anti-BTV antibodies. The sections were deparaffinised and 
rehydrated in graded alcohol followed by gently rinsing in distilled water (DW). The antigen retrieval was per-
formed by microwave in 10 mM tri-sodium citrate buffer (pH 6.0) for 15 min (3 cycles of 5 min each) to unmask 
the antigenic sites, and sections were left to cool at RT for 20 min. Then the slides were washed with PBS (pH 7.4; 3 
times of 5 min each). Endogenous peroxidase activity was blocked by incubating with freshly prepared 3% hydro-
gen peroxide in 80% methanol for 30 min in dark chamber and sections were washed in PBS (3 times of 5 min 
each). Further, the sections were incubated with 5% normal goat serum (Invitrogen; product no. 016201) in PBS 
for 1 hour at RT in humidified chamber for blocking of non-specific antigen binding sites, followed by washing in 
PBS (3 times of 5 min each). Primary antibody against BTV-1 core antigen raised in rabbit at 1:20 dilution in 1% 
bovine serum albumin was incubated on the sections overnight in humidified chamber at 4 °C. Then, the slides 
were washed thrice with PBS and incubated with peroxidase-conjugated goat anti-rabbit secondary antibody 
(Sigma-Aldrich, St. Louis, Missouri, USA) for 1 hour at 37 °C, followed by washing thrice in PBS for 5 min each. 
To demonstrate the immunolabelling, the slides were incubated with ImmPACT™ DAB peroxidase substrate (Cat 
No. SK-4105; Vector Laboratories, Inc., Burlingame, CA, USA) for 30–60 seconds and sections were washed with 
de-ionised water. The slides were counter stained with Mayer’s haematoxylin and rinsed in tap water. The sections 
were covered with CC/Mount™ aqueous mounting medium (Sigma-Aldrich, St. Louis, Missouri, USA) and then 
dried at RT for 45 min to 1 hour. The sections were examined under the microscope for positive signals. Slides 
prepared from known BTV positive samples were used as positive control.
BTV specific antibody detection. The appearance of group-specific antibodies against BTV were meas-
ured in serum from BTV infected and control pregnant mice using a commercial BTV VP7 cELISA Kit (Cat 
No. 287-5; VMRD Inc., Pullman, WA, USA) according to the manufacturer’s instructions. The results of cELISA 
were expressed as percentage inhibition (PI) values, as follows: [1 − (OD620 nm of test serum/OD620 nm of negative 
control serum)] × 100. The test samples were considered positive when the PI value of the sample is equal to or 
more than 50%.
Haematology. At each sacrificed interval, blood samples were analysed for red blood cell (RBC) count, total 
leukocyte count (TLC), packed cell volume (PCV), haemoglobin (Hb), total platelet count (TPC), differential 
leucocyte count (DLC), mean corpuscular volume (MCV), mean corpuscular haemoglobin (MCH), and mean 
corpuscular haemoglobin concentration (MCHC) using automated blood analyzer (Horiba, ABX Micros ESV60, 
Japan).
Separation of peripheral blood mononuclear cells (PBMCs). Anti-coagulated blood was pooled 
according to the experimental groups for isolation of PBMCs as described previously26 and diluted with 1x 
Dulbecco’s phosphate buffered saline (D-PBS; pH 7.2; ratio 1:1) without calcium and magnesium. The blood 
was subjected to density gradient centrifugation method using Histopaque® (Sigma Aldrich, St. Louis, Missouri, 
USA) with a density of 1.083 g/ml. Equal volume of diluted blood (ratio 1:1) was slowly layered over the 
Histopaque® without mixing and centrifuged at 2000 rpm for 15 min at RT, resulting in separation of PBMCs 
at plasma-histopaque interface. The PBMC layer was collected carefully without disturbing the plasma and his-
topaque layer, and washed twice in isotonic PBS at 2000 rpm for 5 min. To remove the traces of RBCs, 1 ml of 
1x RBC lysis buffer was added and incubated for 10 min in ice and centrifuged at 2000 rpm for 5 min. The final 
PBMC pellet was resuspended in 200 μl of stain buffer (BD Pharmingen™, BD Biosciences, San Jose, CA, USA) 
containing heat-inactivated foetal bovine serum (FBS) and sodium azide to maintain cell viability and maximise 
fluorescence signal intensity. Cell number and viability were counted by trypan blue dye exclusion method in 
Neubauer chamber after 1:10 dilution with trypan blue solution (0.01%) and the cell concentration was adjusted 
to 1 × 106/ml of cells.
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Separation of splenocytes. Splenocytes were separated from spleen by mincing into small pieces as 
described previously26. The splenocytes were squeezed from the splenic capsule in PBS (pH 7.4) through 70 μm 
nylon mesh cell strainer in a Petri dish to create a single cell suspension by gently mashing spleen pieces with rub-
ber end of a plunger from 1 ml tuberculin syringe. The suspensions of dispersed cells were again filtered through 
cell strainer into a sterile centrifuge tube on ice. Then, cells were centrifuged at 2000 rpm for 5 min at 4 °C and 
supernatant was discarded. The cell pellet was re-suspended in chilled 1x RBC lysis buffer to remove traces of 
RBCs and centrifuged at 2000 rpm for 5 min at 4 °C. Supernatant was discarded and the final cell pellet was resus-
pended in 200 μl of stain buffer. Cell number and viability were counted by trypan blue dye exclusion method in 
Neubauer chamber and the cell concentration was adjusted to 1 × 106/ml of cells.
Fluorescence-activated cell sorting (FACS). Mouse T lymphocyte subset monoclonal antibody cocktail 
with isotype control labelled with PE-Cy™7 CD3e, PE CD4, and FITC CD8 (Cat No. 558391) for estimation of 
CD4+ and CD8+ T lymphocyte subsets in PBMCs and splenocytes, and PE-Cy™7 mouse antimouse NK-1.1, 
clone PK136 (Cat no. 552878, BD Pharmingen™, BD Biosciences, San Jose, CA, USA) were used in the study. 
Flow cytometric analysis was performed for evaluation of percentage of CD4+ and CD8+ T lymphocyte subsets, 
and NK cells in PBMCs and splenocytes in the infected and control groups. The protocol for FACS analysis was 
followed: 15 μl of mouse T lymphocyte subset antibody cocktail was added in one set of sample, and 15 μl of 
anti-mouse NK-1.1 antibody was added in another set of sample as per the manufacturer’s recommendations. 
Samples were then mixed gently and incubated at RT in dark for 45 min. The tubes were kept in icebox in dark 
and taken for FACS analysis. Ten thousand cells were counted and analysis was performed in the BD FACS Canto 
II Flow Cytometer using FL1 (CD8-FITC), FL2 (CD4-PE) and FL3 (NK-PE-Cy™7) band pass filters. The data 
were analyzed using BD CellQuest™ Pro Software (BD Bioscience, San Jose, CA, USA).
Analysis of early apoptotic cells in PBMCs. Following BTV-1 infection, apoptosis was studied in PBMCs 
at the specified intervals using TACS® Annexin V-FITC Apoptosis Detection Kit (Cat. No: 4830-01-K, Trevigen, 
Inc) and analyzed using flow cytometry. Following protocol was used to process the samples for FACS analysis; 
the isolated PBMCs (1 × 106/100 μL of cells per sample) were washed with chilled 1x PBS buffer on ice. 100 μL of 
Annexin V incubation reagent was prepared freshly by mixing 10 μL of 10x binding buffer, 10 μL of propidium 
iodide (PI), 1 μl of Annexin V-FITC, and 79 μl of deionized DW. The cells were resuspended and incubated with 
100 μl of prediluted Annexin V reagent in the dark for 15 min at RT and 400 μl of 1x binding buffer was added 
to the samples and tubes were kept in icebox in dark and taken for FACS analysis within one hour for maximal 
signal. Ten thousand cells were counted and analysis was performed in the BD FACS Canto II Flow Cytometer 
(BD Biosciences, USA) using FL1 (Annexin V-FITC-early apoptotic) and FL3 (PI-late apoptotic or necrotic) band 
pass filters. The data were analyzed using BD CellQuest™ Pro Software (BD Bioscience, San Jose, CA, USA) and 
the results were plotted as percentage of annexin-V+PI− cells.
Detection of apoptotic cells in formalin fixed tissues. Duplicate formalin fixed tissue sections were 
taken on APES coated glass slides for in situ detection of apoptotic cells using In Situ Cell Death Detection Kit, 
AP (Sigma-Aldrich, St. Louis, Missouri, USA) as per manufacturer’s protocol. Briefly, formalin fixed paraffin 
embedded tissues were deparaffinised and rehydrated through descending graded alcohol. The sections were 
incubated with proteinase-K solution (20 μg/ml) for 20 min at 37 °C. The sections were washed thrice with PBS for 
5 min each, incubated with 50 μl of TUNEL reaction mixture containing 5 μl of enzyme solution and 45 μl of label 
solution, and incubated for 1 hour at 37 °C in humidified chamber in dark. The slides were again washed thrice in 
PBS and viewed under fluorescence microscope for the positive signals.
Alizarin red staining. Alizarin red staining was performed to characterize the skeleton deformities in the 
foetuses born from BTV-1 infected and control pregnant mice at 20/21 GD. The procedure for alizarin red stain-
ing for each group was followed as described by Ovchinnikov27. The length of the foetuses, different bones in 
forelimb (scapula, humerus, radius and ulna) and hind limb (femur, tibia and fibula), vertebral column length 
(cervical–sacral), and skull (length and diameter) were measured using Olympus SZ61 stereo zoom microscope 
with Olympus SZ2-ILST LED illumination stand.
Statistical analysis. The data were analyzed using GraphPad Prism, Version 5.0 (GraphPad Software Inc, 
San Diego, CA, USA). The mean of the infected and control groups at specified time intervals were calculated and 
expressed as mean ± standard error of the mean (SEM). Unpaired t test, one-way ANOVA with Tukey’s post-test, 
two-way ANOVA with Bonferroni post-test were used at suitable places to know the effects of BTV-1 in early and 
mid stages of gestation and uninfected control pregnant groups. For all comparisons, differences were considered 
significant at P < 0.05.
Results
Clinical signs. The clinical signs were recorded over a period of 20/21 GD in both infected and control 
groups. The BTV-1 infected IFNAR1-blocked early stage pregnant mice showed signs of dullness and depression 
on 2 dpi. The clinical signs became more prominent in dams on 3 dpi onwards with conjunctivitis, anorexia, and 
weight loss. Signs of abortions or stillbirth like fetal discharge, bleeding, and bloody staining around the vagina 
were noticed from 7 dpi onwards. The clinical signs were more severe on 7 to 15 dpi due to disease progression 
but after 15 dpi, clinical signs gradually subsided.
The prominent clinical signs in dam infected with BTV-1 during mid stage of gestation (8 GD) were loss of 
appetite (2 dpi), depression (3 dpi), conjunctivitis (5 dpi), ocular and nasal discharges (5 dpi), weight loss, and 
sluggish movements with huddling tendency (7 dpi). Signs of abortions or stillbirth were noticed from 5 dpi 
onwards. The foetuses born at 20/21 GD showed neurological signs. Mortality in dams was not observed during 
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the experimental period in both groups of pregnant mice. The control groups similarly did not show any clinical 
signs or mortality during the experimental period.
Body weights of foetuses in the various groups sacrificed on 20/21 GD were depicted in Supplementary 
Fig. S1. The foetuses born from BTV-1 infected groups showed significant decrease in body weights compared 
to uninfected control foetuses. Foetuses from mid gestation showed non-significantly decreased body weight 
compared to early gestation.
Gross lesions in early gestation. In dams infected at early stage of gestation showed reduced implantation 
sites, early embryonic deaths, abortions, haemorrhages, and necrosis in the placentae and uteri. In uterine lumen, 
deciduas had necrosis with central depression. Early embryonic deaths characterized by loss of embryos (abor-
tions), discoloured and shrunken embryos, and detachment from implantation sites resulted in without embryos on 
9 dpi (Fig. 1b). The uterine mucosa was found edematous and often necrosed with engorged uterine arteries 
(Fig. 1b). Discolouration of amniotic fluid, development of gelatinous consistency, detachment and/or absence of 
placentomes was noticed on 12 dpi onwards. Early embryonic death and fetal resorption without uterine swelling 
was found in one uterine horn with uneven uterine swelling in another horn was noticed in dams (Supplementary 
Tables S1, 2). Severe congestion, haemorrhages, necrosis, and mummification of foetuses were noticed from 15 
dpi onwards (Fig. 1c).
It was noticed that in the stomach of BTV-1 infected dams contained remnants of aborted embryos and/
or foetuses (Fig. 1d). Also there were enlarged and congested spleens and axillary and inguinal lymph nodes. 
Congestion and petechial haemorrhages in different organs like lungs, myocardium, kidneys, and liver were also 
observed. The control animals did not reveal any significant changes (Fig. 1a).
Gross lesions in mid gestation. The dams infected at mid stage of gestation revealed severe conges-
tion, haemorrhages, and edema of brain in foetuses. Severe congestion of uterine horns was noticed on 5 dpi. 
Haemorrhages and resorption of embryos were noticed on 7 dpi (Fig. 2a). Blood clot formation was observed 
in amniotic cavity on 9 dpi. Discolouration of uterus with unequal and asymmetrical embryonic distribution in 
the uterine horns was observed on 13 dpi. Placentas wall become shrunken, discoloured, congested, haemor-
rhagic and necrotic with adherence of yolk sacs to the chorionic surface along with fetal mummification on 13 
dpi (Fig. 2d). Developmental anomaly like micromelia with syndactyly characterized by shorter hind limb with 
fusion of toes was observed in one foetus on 13 dpi (Fig. 2b).
There were enlarged and edematous axillary and inguinal lymph nodes, and focal areas of consolidation in 
lungs on 7 dpi in dams. Markedly enlarged and congested spleen was observed on 9 dpi. Congestion was also 
observed in tracheas, hearts, livers, and kidneys on 5 dpi onwards. The reproductive organs and foetuses of unin-
fected control mice did not show any significant gross lesions (Fig. 2b,c).
Histopathological lesions in early gestation. The tissues from dead and resorpting embryos revealed 
massive necrotic foci with basophilic nuclear remnants and marked infiltration of neutrophils and lymphocytes 
on 7 (Fig. 3a-c) and 9 dpi. The embryos retrieved later were markedly infiltrated with macrophages, plasma cells 
and neutrophils on 12–18 dpi (Fig. 1e,f). Marked congestion in the lamina propria of yolk epithelium was noticed 
on 12 dpi onwards and necrotic cellular debris consisting of predominantly neutrophils with a few macrophages 
in the placenta and also in its labyrinth zone were observed on 15 dpi (Fig. 1g). Severe congestion, haemorrhages, 
and necrosis in mucosa and submucosa of uteri were noticed on 7 dpi onwards (Fig. 1h). Vacuolar degeneration 
and dilatation of endometrial glands in lamina propria of uteri were also observed on 12–15 dpi. Apoptosis and 
degeneration of tertiary follicles of ovary were observed on 19/20 dpi.
Lymphoid depletion in spleens, lymph nodes and thymus of BTV-1 infected dam on 7 dpi and foetuses 
on 19/20 dpi were noticed. White pulp hyperplasia in spleens of dams was noticed on 15 dpi. Engorgement of 
inter-alveolar capillaries and haemorrhages in lungs of dams and foetuses were observed. Interstitial pneumonia 
and peribronchiolar lymphocytic infiltrations were observed in dams on 7–9 dpi. Multifocal interstitial lympho-
cytic infiltration was noticed in myocardium of dams on 7–9 dpi. The uninfected control animals did not reveal 
any histopathological lesions.
Histopathological lesions in mid gestation. Meningo-encephalitis, vascular lesions (congestion, 
haemorrhages, and endothelial cell swelling), and vacuolations in brain parenchyma were the most prominent 
microscopic findings in BTV-1 infected foetuses (Fig. 2e-h). Significantly reduced mass of brain parenchyma 
was observed in BTV-1 infected group on 12/13 dpi. Marked thickening of meninges due to congestion of blood 
vessels, infiltration of inflammatory cells and swollen endothelial cells occurred from 9 dpi onwards (Fig. 2e). 
Marked cerebral edema characterized by numerous empty, irregular shaped vacuoles in the grey and white matter 
of cerebrum, cerebellum and hippocampus was observed on 12/13 dpi (Fig. 2f). Perivascular edema and haem-
orrhages, necrosed and swollen endothelial cells occluding the lumina of capillaries were also observed on 13 dpi 
(Fig. 2g,h). Perivascular cuffing with lymphocytes and necrotizing encephalitis in cerebrum with homogenous 
eosinophilic areas of malacia (necrosis) surrounded by glial cells were observed on 12/13 dpi (Fig. 4a,b). Diffuse 
and focal infiltration of glial cells was noticed in cerebrum. Marked dilatation of lateral ventricles of brain with 
haemorrhages, and severe congestion in subventricular zone were recorded. In fetal lungs, infiltration of plasma 
cells, macrophages, and lymphocytes in pleural spaces was noticed (Fig. 4g).
Marked congestion and irregular dilatation of spiral arteries, and haemorrhages with disruption of decidua 
basalis, basal zone and labyrinth zone of placenta were observed on 9 dpi (Supplementary Fig. S2a). Metrial gland 
area of the placenta had necrosis and was heavily infiltrated with neutrophils, macrophages, and few plasma 
cells and lymphocytes on 9 dpi (Supplementary Fig. S2a,b). Necrosis of labyrinth zone and trophoblast cells, 
and decreased thickness of trophoblastic septa with absence of blood (RBCs) in maternal and fetal sinusoids 
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Figure 1. Gross (a–d) and histopathological (e–h) lesions in BTV-1 infected early gestation group. (a) Normal 
embryos (arrow) in the uterine lumen of uninfected control mice on 9 dpi. (b) Loss of embryos leaving only 
implantation sites (black arrow) in BTV-1 infected mice on 9 dpi. Oedematous and necrosed uterine mucosa with 
dead, shrunken, and discoloured embryo (blue arrow). (c) Severe congestion, haemorrhages and mummification 
of foetus in BTV-1 infected mice on 15 dpi. (d) Stomach of BTV-1 infected dam had digested contents of 
aborted foetuses (arrow) on 15 dpi. (e) Advanced stage of resorpting embryo (blue dotted line) infiltrated 
with inflammatory cells and necrotic placenta on 12 dpi. H&E x40. (f) Higher magnification of necrotic 
placenta showed severe infiltration of neutrophils and few macrophages. H&E x400. (g) Multifocal necrotic 
and inflammatory cell infiltrated areas (asterisk) in labyrinth zone of placenta on 15 dpi. H&E x100. (h) Severe 
haemorrhages (arrow) and necrosis (asterisk) in the mucosa and submucosa of uterus on 9 dpi. H&E x200.
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Figure 2. Gross (a–d) and histopathological (e–h) lesions in BTV-1 infected mid gestation group. (a) Hemorrhagic,  
dead and resorption of embryo in BTV-1 infected group on 7 dpi. (b) BTV-1 infected foetus showed micromelia and 
syndactyly (arrow) on 13 dpi. (c) Symmetrical distribution of reddish discoid shape placenta of uninfected pregnant 
mice on 13 dpi. (d) Shrunken discoloured and necrosis of placenta (yellow arrow) with fetal mummification (yellow 
circle) in BTV-1 infected group on 13 dpi. (e) Marked thickening of meninges due to congestion, haemorrhages, 
edema, and infiltration of inflammatory cells on 9 dpi. H&E x200. (f) Numerous empty, irregular shaped vacuoles 
indicated severe diffuse cerebral edema on 12 dpi. H&E x400. (g) Necrosis of endothelial cells, haemorrhages 
and mild perivascular cuffing in brain on 12 dpi. H&E x200. (h) Perivascular edema and swollen endothelial cells 
occluding the lumen of capillaries on 13 dpi. H&E x400. Inset showing localization of BTV in endothelial cells.  
IP-DAB-MH x200.
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in labyrinth zone of placenta were observed on 7 dpi onwards. In yolk sac epithelium, vacuolar degeneration, 
congestion, fusion and necrosis, and leukocytic infiltration in lamina propria were observed on 9 dpi onwards 
(Supplementary Fig. S2c). In uteri, congestion of spiral arteries with marked infiltration of lymphocytes in 
perivascular areas, mesometrium and myometrium were observed on 7 and 9 dpi (Supplementary Fig. S2d). 
Apoptotic and degenerating tertiary follicles of ovary were observed on 7-12/13 dpi.
Figure 3. Histopathological (a–c) and immunohistochemical (d–f) findings in BTV-1 infected early gestation 
group. (a) Dead and resorpting embryo showed massive necrotic areas with infiltration of inflammatory cells 
on 7 dpi. (b,c) Severe necrosis of embryonic stromal cells with basophilic nuclear remnants and infiltration 
of neutrophils and lymphocytes in the embryo on 7 dpi. (d) Positive immunolabelling of BTV-1 antigen in 
endometrial stromal cells and decidual cells. IP-DAB-MH x200. (e) Positive immunolabelling of BTV-1 antigen 
in metrial glands, decidual and embryonic stromal cells. IP-DAB-MH x200. (f) Positive immunolabelling of 
BTV-1 antigen in cells of mesometrium and metrial glands. IP-DAB-MH x200.
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Figure 4. BTV-1 induced lesions (a,b,g), immunohistochemical localization (c,d,h) and apoptosis (e,f) 
in the foetuses born from dams infected during mid stage of gestation. (a) Perivascular cuffing with 
lymphocytes, congestion and swollen endothelial cells on 18 dpi. H&E x400. (b) Necrotizing encephalitis in 
cerebrum: Eosinophilic areas of malacia (necrosis) surrounded by glial cells on 20 dpi. H&E x200. (c) Positive 
immunolabelling of BTV-1 antigen in the cytoplasm of neurons, endothelial cells, and glial cells in brain. IP-
DAB-MH x200. (d) Brain did not show positive immunoreaction in uninfected control mice. IP-DAB-MH 
x200. (e) Apoptotic cells showed green fluorescence signals in the brain of BTV-1 infected group. FITC x200. (f) 
Negative control: Brain showing no positive immunoreaction for BTV-1 antigen. (g) Infiltration of plasma cells, 
macrophages and lymphocytes in pleural space of lungs on 18 dpi. H&E x200. (h) Positive immunolabelling of 
BTV-1 antigen in alveolar epithelial cells of lung on 18 dpi. IP-DAB-MH x 200.
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Lymphoid depletion in cortex of lymph node and white pulp of spleen was observed in the BTV-1 infected 
dam on 3 dpi. Hyperplasia of white pulp of spleen was observed on 5 dpi onwards. Congestion and haemor-
rhages in cortical and medullary areas, degeneration and necrosis of proximal and distal convoluted tubules were 
recorded in kidneys on 7–9 dpi. Mononuclear cell infiltrations were noticed in myocardium on 5 to 7 dpi. In liver, 
lymphocytic infiltrations around portal areas, hepatocyte degeneration and centrilobular micro and macro vacu-
olations in the hepatocytes were observed on 7 to 9 dpi.
Quantification of BTV genome by qRT-PCR. The BTV was detected in 12 of 21 (57.14%) samples from 
uterus/placenta of dams infected during early stage of gestation. Infection at mid stage of gestation resulted in 
transmission of BTV in 15 of 21 (71.43%) samples from placenta of dams. The BTV viral RNA quantified in 
reproductive organs of dams like uterus/placenta, embryo/foetus, and ovary of early and mid gestation group 
have been summarized in Fig. 5a,b. Similarly, the BTV viral RNA quantified from blood, spleen, lungs, thy-
mus, heart, and brain of dams from early and mid stages of pregnant group at specified time points (Tables 2, 3; 
Fig. 5a,b). The BTV viral RNA quantified in fetal organs like brain, thymus, lungs, heart, and spleen born from 
early and mid stages of gestation (Supplementary Fig. S3). The BTV RNA was detected in blood on 1 dpi and 
highest copy number was detected on 9 dpi. In uterus and placenta, BTV RNA was detected from 3 dpi onwards 
and highest copy number was detected on 9 dpi (early) and 7 dpi (mid gestation). In embryo/foetus, BTV RNA 
was detected on 5 dpi (early), and 3 dpi (mid gestation). In ovary, lungs, thymus, and heart, BTV was detected 
from 3 dpi onwards in both groups except brain on 5 dpi in early gestation. The uninfected control mice were 
negative for BTV RNA by qRT-PCR.
Immunohistochemistry. In early stage of pregnant mice, positive immunolabelling of BTV-1 antigen was 
noticed in embryonic stromal cells, decidual cells (Fig. 3d), cells of mesometrium and metrial glands (Fig. 3e,f), 
and infiltrated lymphocytes in the necrosed embryos on 5 dpi onwards. Foetuses from mid stage of pregnant mice 
Figure 5. Quantification of BTV RNA in blood, spleen, uterus/placenta and embryo/foetus of pregnant mice 
infected with BTV-1 during early (a) and mid (b) stages of gestation at various time points using TaqMan 
probe-based real-time PCR assay. Results are presented as bar diagram with mean value and standard error 
of the mean (SEM) at each time point (n = 3). Virus load in blood is given as log10 copies of viral RNA ml−1 of 
samples and virus load in tissues is given as log10 copies of viral RNA g−1 tissue.
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showed BTV-1 antigen in cells of dura mater and pia mater of brain. BTV-1 antigen was also demonstrated in 
swollen endothelial cells of capillaries, cytoplasm of neurons, and glial cells in the brain (Fig. 4c). BTV-1 antigen 
was also demonstrated in alveolar epithelial cells of fetal lungs of both groups on 18 dpi (Fig. 4h).
Both early and mid stages of pregnant mice showed BTV-1 antigen in luminal and glandular epithelium and 
stromal cells in the lamina propria of the uterus (Fig. 6a). Strong positive immunolabelling of BTV-1 antigen was 
demonstrated in granulosa cells, theca interna and externa of secondary and tertiary follicles, cortical stroma, 
and small theca lutein cells and large granulosa lutein cells of corpus luteum (CL) of ovary (Fig. 6c,d). BTV-1 
antigen was demonstrated in yolk sac epithelial cells of placenta. In reproductive organs (uterus, placenta, ovary, 
and embryo), the intensity of immunohistochemical signals were more in group infected during early gestation 
than during mid gestation. In fetal brain, intensity of immunohistochemical signals were more in mid gestation. 
Uterus, brain, and yolk sac epithelial cells of placenta of uninfected control mice did not show any positive immu-
noreactions (Fig. 6b).
Humoral immune response. Humoral immune response was assessed by detecting BTV specific antibod-
ies. The pregnant animals infected with BTV-1 during early stage of gestation were negative for BTV specific anti-
bodies up to 5 dpi. The BTV infected dam serum samples showed positivity with PI values of more than 50% on 7 
dpi and levels reached peak on 15 dpi (83.24%), and thereafter started to decline. During infection at mid stage of 
gestation, serum samples were found negative for BTV antibodies up to 3 dpi, and 5 dpi onwards showed positive. 
The antibody levels were significantly increased on 9 dpi (84.26%), and thereafter started to fall. The uninfected 
control animals of both groups were remained negative for BTV antibodies with less than 50% PI values.
Assessment of Cell Mediated Immunity
Haematology. BTV-1 infected mice during early stage of gestation showed constantly decreased TLC 
(P < 0.001) and lymphocyte counts (P < 0.05) up to 7 dpi. Subsequently, TLC and lymphocyte counts started 
to increase to non-significantly levels on 15 dpi (Supplementary Fig. S4a,c). The neutrophil counts in BTV-1 
infected group were non-significantly increased on 5–9 dpi (Supplementary Fig. S4e). Monocyte counts in early 
stage infected group was decreased on 7 dpi and thereafter increased. The eosinophil and basophil counts did 
not show any significant variations. The RBC, TPC, Hb, and PCV values showed decreasing trend up to 7 dpi 
and thereafter increased to normal on 19/20 dpi. The MCV and MCHC values remained almost normal in both 
groups.
BTV-1 infected mice during mid stage of gestation showed significantly decreased TLC (P < 0.05) and 
non-significantly decreased lymphocyte counts on 7 dpi. The TLC values, however, became normal with sig-
nificantly (P < 0.05) increased lymphocyte counts on 12/13 dpi (Supplementary Fig. S4b,d). Neutrophil counts 
showed non-significant changes (Supplementary Fig. S4f). Monocyte counts in infected group increased 
non-significantly on 7–9 dpi. Eosinophil and basophil counts did not show any significant changes in the infected 
mice. The RBC, TPC, Hb, and PCV values revealed slight decrease on 7–9 dpi in BTV-1 infected group. The MCV 





1 2 3 5 7 9 12 15 18 19/20
Lungs ND ND 0.72 1.15 2.56 3.69 2.96 2.24 1.59 1.26
Thymus ND ND 0.96 2.36 3.94 3.85 3.23 2.85 1.86 1.63
Heart ND ND 1.93 3.29 4.27 4.88 3.94 3.07 2.58 2.16
Brain ND ND ND 0.68 0.92 1.84 1.34 1.19 1.16 1.09
Ovary ND ND 0.87 2.79 4.53 4.19 3.52 3.26 2.76 2.35
Table 2. Quantification of BTV RNA from various tissues of pregnant mice infected with BTV-1 during early 
stage of gestation at various time points using TaqMan probe-based real-time PCR assay. n = 3 at each time 




1 2 3 5 7 9 12/13
Lungs ND ND 0.87 1.36 2.78 3.82 3.06
Thymus ND ND 1.03 2.53 3.68 4.16 3.17
Heart ND ND 2.16 3.7 4.72 4.9 3.67
Brain ND ND 0.73 1.18 1.85 2.1 2.35
Ovary ND ND 1.17 2.86 4.6 3.93 3.72
Table 3. Quantification of BTV RNA from various tissues of pregnant mice infected with BTV-1 during mid 
stage of gestation at various time points using TaqMan probe-based real-time PCR assay. n = 3 at each time 
point; ND: Not detected; virus load in tissues is given as log10 copies of viral RNA g−1 tissue.
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Kinetics of CD4+ and CD8+ T cells in spleen and PBMCs. Analysis of T lymphocyte subsets in spleen 
and PBMCs of pregnant mice infected with BTV-1 during early stage of gestation revealed significant (P < 0.05) 
changes at various time points (Fig. 7B). In spleen, CD4+ and CD8+ T cells were constantly decreased and signif-
icant decrease was recorded on 7 dpi. Subsequently, there was increase, but only CD8+ T cells showed significant 
(P < 0.001) peak increase on 15 dpi. In PBMCs, CD4+ and CD8+ T cells were non-significantly decreased on 7 
dpi, and thereafter only CD8+ T cells were significantly (P < 0.01) increased on 15 dpi (Fig. 7B).
The kinetics of T lymphocyte subsets in spleen and PBMCs of mid gestation mice revealed significant changes 
at various time points (Fig. 7A,B). In spleen, CD4+ T cells were constantly increased from 3 dpi and significantly 
peaked on 7 dpi in BTV-1 infected group thereafter, the cells were decreased. In spleen, CD8+ T cells constantly 
increased up to 7 dpi and significant (P < 0.001) increase was observed on 5, 7, 9, and 12/13 dpi (Fig. 7A); how-
ever, these cells were decreased after 7 dpi. In PBMCs, CD4+ cells showed non-significant changes; however, 
CD8+ T cells significantly (P < 0.001) increased on 5, 7, 9, and 12/13 dpi. In uninfected control group, CD4+ and 
CD8+ T cells showed normal physiological fluctuations during pregnancy at same time points (Fig. 7B).
Kinetics of CD4+ and CD8+ T cells ratio. The CD4+ and CD8+ T cells ratio in spleen and PBMCs of early 
gestation mice revealed significant changes at various time points in BTV-1 infected group (Fig. 7B). In spleen 
and PBMCs, CD4+ and CD8+ T cells ratio was significantly increased on 7 dpi, but thereafter, the levels were 
non-significantly decreased in infected group.
The CD4+ and CD8+ T cells ratio in spleen and PBMCs of mid gestation mice revealed significant changes 
at various time points in BTV-1 infected group (Fig. 7B). The CD4+ and CD8+ T cells ratio was significantly 
decreased from 3 (spleen) and 5 (PBMCs) dpi onwards in BTV-1 infected group due to significantly increased 
CD8+ T cells. There was no specific trend in CD4+ and CD8+ T cells ratio noticed in the uninfected control group.
Kinetics of NK cells in spleen and PBMCs. The kinetics of NK cells in spleen and PBMCs of early gesta-
tion mice revealed significant changes at specified time intervals in BTV-1 infected group (Fig. 7B). In spleen, NK 
cells population significantly (P < 0.05) and in PBMCs, non-significantly increased on 1 dpi. Subsequently, the 
levels were decreased up to 7 dpi and thereafter, the levels significantly increased on 12, 15, and 18 dpi in spleen 
and non-significantly increased in PBMCs of BTV-1 infected group. There was no specific trend noticed in NK 
cells in spleen and PBMCs of uninfected control group.
Figure 6. Immunohistochemical localization of BTV-1 antigen in early gestation group. (a) Positive 
immunolabelling of BTV-1 antigen in luminal epithelium, endometrial glands, and stromal cells of uterus on 
7 dpi. IP-DAB-MH x200. (b) Uterus did not show positive immunoreaction in uninfected control mice. IP-
DAB-MH x200. (c) Strong positive immunolabelling of BTV-1 antigen in granulosa cells, theca interna and 
externa of follicles, and cortical stromal cells of ovary. IP-DAB-MH x200. (d) Strong positive immunolabelling 
of BTV-1 antigen in cortical stromal cells, small theca lutein cells, and large granulosa lutein cells of corpus 
luteum of ovary. IP-DAB-MH x200.
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Figure 7. (A) Dot-plot showing flow cytometric analysis of CD4+ and CD8+ T lymphocytes after staining 
with PE and FITC, respectively in uninfected control (a) and BTV-1 infected groups (b,c,d) during mid stage 
of gestation at 3 (a,b), 5 (c), and 7 dpi (d). Representative figures of two independent experiments are shown. 
Lower right quadrant (FL2-H) represents CD4+ T lymphocytes (PE), while upper left quadrant (FL1-H) shows 
CD8+ T lymphocytes (FITC). (B) Effect of BTV-1 infection on immune cell populations at various time points 
of pregnant mice infected with BTV-1 during early (a,c,e,g) and mid (b,d,f,h) stages of gestation, and uninfected 
control group. CD4+ T lymphocytes (a,b), CD8+ T lymphocytes (c,d), CD4+/CD8+ ratio (e,f) and natural 
killer cells (g,h) in PBMCs (black solid line and square dot line) and spleen (red round dot line and long dash 
line). Results are presented as line diagram with mean ± SEM at each time point (n = 3). Two-way ANOVA with 
Bonferroni post-test was used. *P < 0.05, **P < 0.01 and ***P < 0.001 statistically significant compared with 
uninfected control group.
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The kinetics of NK cells in spleen and PBMCs of mid stage pregnant mice, revealed significant (P < 0.01) 
increase at 1 dpi in BTV-1 infected group (Fig. 7B). Subsequently, the levels were decreased up to 7 dpi and there-
after, the levels increased. There was no specific trend noticed in NK cells in spleen and PBMCs in the uninfected 
control group.
Detection of apoptotic cells in PBMCs. The role of apoptosis in BTV-induced pathogenesis during early 
(Supplementary Fig. S5a–c) and mid stages of gestation by quantifying the annexin V-FITC labelled early apop-
totic cells in PBMCs at the specified intervals by flow cytometry was investigated. The percentage of apoptotic 
cells in PBMCs reached peak levels on 7 dpi (Supplementary Fig. S5) and significantly increased on 5–18 dpi in 
early and on 3 to 12/13 dpi in BTV-1 infected mid gestation group. There was no specific trend noticed in the 
percentage of apoptotic cells in PBMCs of uninfected control group (Supplementary Fig. S5).
In situ detection of apoptotic cells in tissues. BTV-1 induced apoptotic cell death was detected in for-
malin fixed and paraffin embedded tissue sections of embryo (early gestation), placenta, uterus, ovary, lymph 
nodes, spleen, and brain of both groups (Figs. 4e,f, 8a–d). Increased number of BTV-1 induced green fluorescence 
signals of apoptotic cells were detected on 7 to 9 dpi. Uninfected control animals showed very few positive signals 
in these organs. Foetuses born from BTV infected mid gestation group showed strong green fluorescence signals 
of apoptotic cells in brain.
Alizarin red staining. The effect of BTV-1 in the skeletal system of foetuses born from early and mid stages 
of gestation at 20/21 GD was studied. The length of different bones in forelimb and hindlimbs, vertebral column 
(cervical–sacral), and skull (length and diameter) of foetuses born from early and mid stages of gestation showed 
significant differences (Table 4). The foetuses born from BTV-1 infected mid stage of gestation showed signifi-
cantly decreased lengths (Supplementary Fig. S6).
Discussion
The present studies perhaps are the first attempts to explore the occurrence of transplacental transmission (TPT) 
of wild-type Indian BTV-1 in pregnant mice during early (infected on 1 GD) and mid (infected on 8 GD) stages of 
gestation. Until 2006, BTV serotypes causing TPT were all ascribed to use of modified or cell attenuated vaccine 
virus strains in cattle6,28,29, sheep30,31, and dogs7. In 2006, BTV-8 in Europe caused significant increase in the inci-
dence of abortions, stillborns, and births of weak or deformed foetuses in sheep, goats, and cattle2,9.
The BTV-l used in the present study, was isolated from aborted and stillborn fetal spleen of goats from 
Sardarkrushinagar, Gujarat, India in 200720. It is postulated that wild type BTV strains might have acquired 
Figure 8. (a) Mild green fluorescence signals of apoptotic cells in yolk sac epithelium of placenta in 
uninfected control mice on 15 dpi. FITC x200. (b) Strong green fluorescence signals of apoptotic cells in 
yolk sac epithelium of placenta in BTV infected mice on 15 dpi. FITC x200. (c) Apoptotic cells showed green 
fluorescence signals in embryo infected with BTV-1 during early stage of gestation. FITC x200. (d) BTV-1 
infected uterine stromal cells showed strong positive green fluorescence signals of apoptotic cells. FITC x200.
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either cell culture adapted vaccine strain properties resulted in TPT1,32,33. Interestingly, TPT in ovine, bovine, and 
caprine species could be involved in the mechanisms of overwintering and introduction of BTV in free regions as 
described in Northern Ireland11. The serotypes of BTV exist as a swarm of closely related sequence variants with 
one or several dominant master sequences (quasispecies)8. Changes in the environment, vector and host species 
can lead to selection of sequence variants with an enhanced or reduced virulence for the new environment. 
These minor viral variants may display phenotypical changes like changes in virulence, tissue tropism, ability to 
cross the placenta and cause fetal infections1,34. However, in contrast, past research findings reveal that natural or 
experimental infection with wild-type BTV serotypes in pregnant cattle and sheep did not show any vertical or 
TPT potential35,36.
In the present study, BTV-1 infection during early stage of gestation resulted in reduced implantation sites, 
early embryonic death, abortion, fetal resorption, mummification, and hemorrrages and necrosis of embryos. 
Exposure of bovine and caprine blastocysts to BTV-8 resulted in active viral replication leads to growth arrest 
and significant levels of cellular apoptosis37,38. This might the reason for lesions noticed during early stage in the 
present study. The results of the present study have been in concordance with the earlier findings5,6,10,30. In Israel 
and Australia, modified live vaccine strain of BTV-23 in pregnant Merino sheep during 35 to 43 days of gestation 
caused 40–56% of early foetal mortality with much lesser extent or no CNS malformations like hydranencephaly 
in their offsprings31,36.
The TPT rate differs significantly depending on species of host, stage of gestation, BTV serotype, route of inoc-
ulation, immunological status of the host, and dose of virus32,33. The present study showed higher rate of TPT dur-
ing mid stage of gestation (71.43%) when compared to early stage (57.14%). The exact mechanism for gestation 
stage dependent TPT of BTV is not yet fully elucidated32,33. The results of the present study were concorded with 
the findings of van der Sluijs et al.14, who reported higher TPT rate (69%) during mid stage of gestation (between 
70 and 75 days of gestation) than early stage (40–45 days of gestation) in ewes. van der Sluijs et al.15 also reported 
67% of TPT rate with BTV-1 and 56% with BTV-8 in ewes. Belbis et al.16 demonstrated 33% of TPT during mid 
stage of gestation (61 days of pregnancy) but not during late stage (135 days) in goats. The TPT rate in cattle under 
the field situation varies from 10 to 41.7%10. Higher rate of TPT during mid stage of gestation could be due to 
more intense blood perfusion of the placental endothelium and increased erythrophagocytosis by the embryonal 
trophoblasts might facilitated the TPT of BTV-1 in the present study32,33,39.
In the present study, stomach of BTV-1 infected dam during early stage of gestation contained digested con-
tents of aborted embryos/foetuses due to cannibalization. Cannibalism was due to loss of maternal instinct owing 
to disturbances in the physical state of the dam. In the present study, BTV-1 induced stress in the dam might be 
responsible for cannibalistic behaviour. Several reports speculated that cannibalism habit is more common in 
dams, which delivered malformed or defective or abnormal offspring40. This cannibalism effect influences repro-
ductive research in rodents, because female mice would selectively cannibalize their malformed offspring40. In the 
present study, this might be the reason for reporting less number of malformed young ones.
In the present study, identification of BTV from foetuses suggested that viraemic foetuses could introduce 
infectious BTV into new regions where suitable vectors are active6,16,32,33. How long these foetuses remain infec-
tious will be the subject of further investigation. Overwintering mechanisms of BTV still unknown, from an epi-
demiological point of view, it would be critical to determine whether TPT would facilitate survival of BTV during 
vector-free period in temperate climates10,15. van der Sluijs et al.14,15 reported the presence of infectious BTV in 
umbilical cord blood and various foetal tissues with severe pathological consequences. In the present study, pos-
itive immunolabelling of BTV-1 antigen was demonstrated in the infiltrated inflammatory cells in mesometrium 
and embryonic stromal cells in the decidua. Since BTV is associated with monocytes, lymphocytes, red blood 
cells and endothelial cells, directly facilitates the virus transfer across the placenta along with migration of mono-
cytes/macrophages, and/or by viral transfer through trophoblast cells7,41–43. During the initial stages of viremia, 
there is evidence for the presence of free virus in the plasma. The present study first time demonstrated the BTV-1 
localization in the placenta and trophoblast cells by IHC.
In the present study, strong positive immunolabelling of BTV-1 antigen was observed in uterus, placenta, 
ovary, and CL. De la Concha-Bermejillo et al.29 demonstrated mild multifocal perivascular cuffing of lympho-
cytes, several microthrombi in the ovaries and CL of BTV infected heifers, but BTV was neither isolated nor 
demonstrated by immunofluorescence or in situ hybridization in ovaries. However, BTV was isolated from the 
uterus of heifers. In the present study, presence of BTV antigen in ovary might have responsible for apoptotic 
changes in ovaries and resulted pregnancy consequences. Presence of high titers of virus in the luteal cells of CL 
resulted in necrosis of infected cells and loss of pregnancy29,44. In the present study, demonstration of BTV from 
Groups




Scapula Humerus Radius Ulna Femur
Tibia and 
Fibula Length Diameter
Control (Pregnant) 1.82 ± 0.03 1.91 ± 0.05 1.97 ± 0.03 1.43 ± 0.03 1.67 ± 0.03 1.87 ± 0.04 13.44 ± 0.37 6.29 ± 0.21 3.25 ± 0.21
Early stage of gestation 1.77 ± 0.03 1.79 ± 0.04 1.75 ± 0.03* 1.21 ± 0.03 1.43 ± 0.03* 1.72 ± 0.04* 11.78 ± 0.44* 5.56 ± 0.25 4.0 ± 0.35
Mid stage of gestation 1.67 ± 0.03* 1.7 ± 0.04* 1.61 ± 0.03*,a 1.09 ± 0.04*,a 1.35 ± 0.04* 1.61 ± 0.03* 11.31 ± 0.42* 5.12 ± 0.21* 4.69 ± 0.22*
Table 4. Effect of BTV-1 infection in the skeletal system of foetuses on 20/21 gestation day. Values bearing 
asterisk (*) differs significantly (P ≤ 0.05) in BTV-1 infected group when compared to uninfected control group 
at specified time intervals (n = 9). aDiffers significantly (P ≤ 0.05) in mid infected group when compared to early 
infected group at specified time intervals. Alizarin red staining was performed to assess the skeletal system.
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ovaries and CL without much ovarian lesions is similar to the findings of Parsonson et al.44 BTV could infect 
luteal cells right after ovulation in viremic animals when high titers of virus are present in blood and the develop-
ing stage of corpus hemorrhagicum29,44.
In the present study, histopathological lesions in uterus and placenta were concorded with the placental 
lesions observed in sheep and cattle infected with BTV14,32,33. Severe microscopic neurological lesions in the 
foetuses during mid stage of gestation were concorded with the previous reports4,15,45. The congenital anomalies 
are mainly due to vascular damage and high affinity of BTV for undifferentiated neuronal precursor cells in the 
brain during development resulting in massive necrosis4,32,33,45. In the present study, gross neurological lesions 
like hydranencephaly or porencephaly in the young ones are not observed. The results were concorded with the 
previous reports that European strain of BTV-8 during mid stage of gestation (62–75 GD) in goat foetuses did 
not produce any neurological lesions even after crossing placenta4,13. It is well documented that transplacental 
infection and associated defects can vary widely in sheep and cattle and is therefore unpredictable7. In the present 
study, congestion and haemorrhages were observed in various organs of BTV-1 infected dam, which was con-
corded with Coetzee et al.13.
In the present study, BTV-inoculated mice had seroconverted by 7 and 5 dpi and reached peak levels by 15 and 
9 dpi in early and mid gestation, respectively. These results were concorded with earlier findings in non-pregnant 
ewes and goats infected with BTV-813,16. Pregnant ewes were inoculated with either field or rescued strains of 
BTV-2 and BTV-8 resulted in seroconvertion by 6 dpi and antibody levels reached the diagnostic threshold level 
by 10 dpi and antibodies levels were maintained up to 28 dpi46. The significantly increased antibody levels were 
well correlated with antigenic stimulation resulted in proliferation of CD4+ and CD8+ T lymphocytes in spleen 
and PBMCs, and germinal centers formation with proliferation of B cell areas in lymph nodes and spleen of dams 
was noticed led to high humoral immune response.
In the present study, BTV-1 infected both groups showed leukopenia and lymphopenia at 7 dpi followed by 
leukocytosis and lymphocytosis at 15 dpi. Further, CD4+ and CD8+ T lymphocytes were significantly decreased 
on 7 dpi and subsequently increased on 15 dpi in spleen and PBMCs. The role of T lymphocyte subsets in the 
modulation of CMI in pregnant animals infected with BTV-1 has not been studied so far. To our knowledge, this 
is the first study constituted the detailed characterization of kinetics of haematological parameters and T lym-
phocyte subsets in spleen and PBMCs in IFNAR1-blocked pregnant mice. CD4 and CD8 T cells work together to 
eliminate the intracellular pathogens including viruses in association with many secretory molecules47.
One of the mechanisms proposed for leukopenia and lymphopenia in sheep was apoptosis48–50. Several studies 
proved that BTV is a potent apoptosis inducer in various mammalian cell lines in vitro and played important role 
in pathogenesis of BT48–50. BTV-induced apoptosis happens through both extrinsic (caspase-8 activation) and 
intrinsic (caspase-9 activation) pathways48,49. In the present study, significantly increased apoptosis of PBMCs 
with significantly decreased TLC and T lymphocyte subsets were observed during peak viraemia on 7 dpi, which 
was probably due to replication of BTV in lymphocytes, monocytes/macrophages, dendritic cells, and stem cells 
of haemopoietic system could result in cellular injury and death of cells43,47,51. These results were corroborated 
with the previous studies of experimental infections in non-pregnant sheep, white-tailed deer, and IFNAR(-/-) 
mice1,51–53.
In the present study, leukocytosis and lymphocytosis with significantly increased CD8+ T cells was 
observed on 15 dpi in early gestation, possibly due to antigen presenting cells got the sufficient time for pro-
cessing and presentation of antigen to CD4 T helper cells, thereby their activation and subsequent proliferation. 
Lymphocytic-proliferative response indicates CMI response. Similar observation has been made by earlier work-
ers in BTV infected non-pregnant sheep and cattle47,50,52. In the present study, CD4+ and CD8+ T cells ratio was 
significantly increased on 7 dpi, when CD8+ T cells levels are significantly low; however, ratio was low on 15 dpi 
in BTV-1 infected early gestation group. Other workers also reported similar findings in sheep infected with 
BTV-1, BTV-8, and BTV-2347,50,52.
In the present study, significantly increased CD8+ T cells was observed on 7 dpi in BTV infected mid gesta-
tion, which resulted in significantly low CD4+ and CD8+ T cells ratio in PBMCs and spleen. The CD8 cytotoxic 
T lymphocytes play an important role in killing of virus infected cells by both secretory and membranolytic path-
way involving granzyme and perforin, and secreting several antiviral cytokines. CD8+ T cells are most important 
cells during murine pregnancy especially at mid-gestation to protect both mother and foetus from infections by 
directly recognizing allogeneic MHC class I molecules and regulation to maintain fetal tolerance. Interestingly, 
viral infections alter the maternal CD8+ T cell response by changing the CD8+ T cell repertoire and increasing the 
influx of CD8+ T cells to decidual tissue. Usually, high T cell activation threshold at the fetal–maternal interface 
may prevent efficient clearance of viral infections. But, increased inflammatory response due to viral infections 
may break fetal–maternal tolerance results in pregnancy complications54,55. T cells are highly migratory and their 
ability to fight infections depends on their tissue localization and their capacity to traffic through different lym-
phoid and peripheral tissues.
Natural killer (NK) cells are part of innate immune system, plays a key role in host first line of defense against 
viral infections56. In the present study, NK cells increased on 1 dpi in early and mid infection and subsequently 
decreased on 7 dpi and again increased on later stages of infection. Mouse models provided evidence that NK 
cells played critical role to control several viral infections like murine cytomegalovirus, poxviruses and influ-
enza virus56,57. To our knowledge, this is the first study regarding kinetics of NK cells in spleen and PBMCs in 
IFNAR1-blocked pregnant mice infected with BTV-1.
In conclusion, present investigation strongly proved the transplacental transmission of wild-type Indian 
BTV-1 and higher rate of TPT during mid stage than early stage of gestation. During early stage, reduced implan-
tation sites and abortion, and mid stage, neurological lesions in foetuses were noticed. BTV-1 antigen was 
first time demonstrated in reproductive organs, embryos, and different fetal organs. Transplacentally infected 
foetuses were viraemic after birth suggested possible source of infection to other animals. Further research 
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remains necessary to investigate the TPT of Indian BTV serotypes in ruminants and to clarify the role of BTV 
in pre-implantation embryos at a molecular level. The protective efficacy of an inactivated pentavalent vaccine 
developed for control of BTV in India would be important to investigate against vertical transmission of BTV 
in pregnant animals. This mice model can also serve to test new vaccines for their efficacy in preventing vertical 
transmission of BTV.
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